nafamostat has been researched along with Bright Disease in 8 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafamostat mesilate was used as an anticoagulant for hemodialysis, because it was during her menstrual period with hypermenorrhea." | 5.31 | Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient. ( Iseki, K; Ishida, A; Mano, R; Muratani, H; Oshiro-Chinen, S; Sakima, A; Takishita, S; Tana, T; Tomiyama, N; Tozawa, M; Yamazato, M, 2002) |
| "Nafamostat mesilate was used as an anticoagulant for hemodialysis, because it was during her menstrual period with hypermenorrhea." | 1.31 | Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient. ( Iseki, K; Ishida, A; Mano, R; Muratani, H; Oshiro-Chinen, S; Sakima, A; Takishita, S; Tana, T; Tomiyama, N; Tozawa, M; Yamazato, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamazato, M | 1 |
| Mano, R | 1 |
| Oshiro-Chinen, S | 1 |
| Tomiyama, N | 1 |
| Sakima, A | 1 |
| Ishida, A | 1 |
| Tana, T | 1 |
| Tozawa, M | 1 |
| Muratani, H | 1 |
| Iseki, K | 1 |
| Takishita, S | 1 |
| Nagai, H | 1 |
| Yamada, H | 1 |
| Matsuura, N | 1 |
| Inagaki, N | 1 |
| Shimazawa, T | 1 |
| Koda, A | 1 |
| Yaoita, E | 1 |
| Kawasaki, K | 1 |
| Yamamoto, T | 1 |
| Kihara, I | 1 |
| Miyata, T | 2 |
| Fujita, Y | 2 |
| Inagi, R | 2 |
| Inoue, I | 2 |
| Sugiyama, S | 2 |
| Maeda, K | 2 |
| Shinzato, T | 1 |
| Miyama, A | 1 |
| Porcel, JM | 1 |
| Ueda, M | 1 |
| Deguchi, M | 1 |
| Takemura, S | 1 |
| Kasamatsu, Y | 1 |
| Yanagida, K | 1 |
| Fukuda, W | 1 |
| Okamoto, M | 1 |
| Onodera, H | 1 |
| Sugino, S | 1 |
| Kondo, M | 1 |
| Ikehara, S | 1 |
| Shimamura, K | 1 |
| Aoyama, T | 1 |
| Fujii, S | 1 |
| Hamashima, Y | 1 |
8 other studies available for nafamostat and Bright Disease
| Article | Year |
|---|---|
Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient.
Topics: Abdominal Pain; Adult; Anticoagulants; Benzamidines; Drug Hypersensitivity; Female; Fibrinolysin; Gl | 2002 |
The effect of 6-amidino-2-naphtyl-4-guanidinobenzoate dimethane sulfonate (FUT-175) on experimental glomerulonephritis in mice.
Topics: Animals; Benzamidines; Complement Inactivator Proteins; Cyclophosphamide; Disease Models, Animal; Fe | 1984 |
[Effect of FUT-175 on rat experimental nephritis. II. Rat BSA nephritis].
Topics: Animals; Antigen-Antibody Complex; Benzamidines; Complement Inactivator Proteins; Glomerulonephritis | 1984 |
Effectiveness of nafamostat mesilate on glomerulonephritis in immune-complex diseases.
Topics: Benzamidines; Complement Inactivator Proteins; Cryoglobulinemia; Glomerulonephritis; Guanidines; Hum | 1993 |
Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia.
Topics: Adult; Benzamidines; Child; Complement Activation; Complement Inactivator Proteins; Complement Syste | 1993 |
[Complement inhibition: a new therapeutic modality?].
Topics: Adult; Animals; Antigens, CD; Benzamidines; Blood Proteins; Carrier Proteins; CD55 Antigens; CD59 An | 1995 |
[The relationship between complement C3 receptors (CR1, CR3) on polymorphonuclear leukocytes and complement fragments during hemodialysis].
Topics: Aged; Aged, 80 and over; Benzamidines; Cells, Cultured; Chronic Disease; Complement C3; Complement C | 1991 |
Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice.
Topics: Animals; Autoimmune Diseases; Benzamidines; Female; Glomerulonephritis; Guanidines; Lupus Erythemato | 1985 |